Progression-free survival: An important end point in evaluating therapy for recurrent high-grade gliomas is a research paper published in Neuro-Oncology (2008). On theSindex it has a DataRank of 15.6. It has been cited 421 times, with 200 citing works in its 1-hop citation network.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.907
From this paper's citation signal
Citation Network Contribution
14.7
From 200 citing papers with measurable signal
NCRR NIH HHS
Grant: M01 RR000042
NCRR NIH HHS
Grant: M01 RR000056
NCI NIH HHS
Grant: U01 CA 62399 022030
NCI NIH HHS
Grant: U01 CA 62407-08
NCI NIH HHS
Grant: U01 CA062407
NCI NIH HHS
Grant: CA 62412
NCI NIH HHS
Grant: CA 62422
NCRR NIH HHS
Grant: M01 RR 0865
NCRR NIH HHS
Grant: M01 RR 00042
NCRR NIH HHS
Grant: M01 RR 00633
NCI NIH HHS
Grant: P30 CA016672
NCI NIH HHS
Grant: CA 62399
NCRR NIH HHS
Grant: M01 RR003186
NCI NIH HHS
Grant: CA 62455-08
NCI NIH HHS
Grant: U01 CA 62405
NCI NIH HHS
Grant: U01 CA062421
NCI NIH HHS
Grant: CA 16672
NCRR NIH HHS
Grant: M01 RR 00056
NCRR NIH HHS
Grant: M01 RR000079
NCI NIH HHS
Grant: U01 CA062412
NCRR NIH HHS
Grant: M01 RR 03186
NCRR NIH HHS
Grant: M01 RR000865
NCI NIH HHS
Grant: U01 CA062422
NCI NIH HHS
Grant: CA 62426
NCRR NIH HHS
Grant: M01 RR 00079
NCRR NIH HHS
Grant: M01 RR000633
NCI NIH HHS
Grant: U01 CA 62421-08
NCI NIH HHS
Grant: U01 CA062399
NCI NIH HHS
Grant: U01 CA062405
NCI NIH HHS
Grant: U01 CA062426
FWCI
17.29
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals